Lung Cancer
Volume 45 , Pages S81-S84 , August 2004

Malignant mesothelioma—British surgical strategies

  • David A Waller

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +44-116-256-3959; fax: +44-116-236-7768.

References 

  1. Baldini EH, Recht A, Strauss GM, DeCamp MM, Swanson SJ, Liptay MJ, et al.  Patterns of failure after trimodality therapy for malignant pleural mesothelioma. Ann. Thorac. Surg. 1997;63:334–338
  2. Rusch VW, Rosenzweig K, Venkatraman E, Leon L, Raben A, Harrison L, et al.  A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma. J. Thorac. Cardiovasc. Surg. 2001;122:788–795
  3. Sugarbaker DJ, Flores RM, Jaklitsch MT, Richards WG, Strauss GM, Corson JM, et al.  Resection margins, extrapleural nodal status and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. J. Thorac. Cardiovasc. Surg. 1999;117:54–65
  4. Edwards JG, Cox G, Andi A, Jones JL, Walker RA, Waller DA, et al.  Angiogenesis is an independent prognostic factor in malignant mesothelioma. Br. J. Cancer. 2001;85:863–868
  5. Butchart EG, Ashcroft T, Barnsley WC, Holden MP. Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura. Experience with 29 patients. Thorax. 1976;31:15–24
  6. Waller DA, Morritt GN, Forty J. Video assisted thoracoscopic pleurectomy in the management of malignant pleural effusion. Chest. 1995;107:1454–1456
  7. Martin-Ucar AE, Edwards JG, Rengarajan A, Muller S, Waller DA. Palliative surgical debulking in malignant mesothelioma. Predictors of survival and symptom control. Eur. J. Cardiothorac. Surg. 2001;20:117–121

PII: S0169-5002(04)00178-3

doi: 10.1016/j.lungcan.2004.04.018

Lung Cancer
Volume 45 , Pages S81-S84 , August 2004

Article Tools

* Image Usage & Resolution